Efficacy and safety of ‘true’ cinnamon (Cinnamomum zeylanicum) as a pharmaceutical agent in diabetes: a systematic review and meta-analysis
Authors:
- 17 March 2013
- journal article
- review article
- Published by Wiley in Diabetic Medicine
- Vol. 30 (4) , 505-506
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Efficacy and safety of ‘true’ cinnamon (Cinnamomum zeylanicum) as a pharmaceutical agent in diabetes: a systematic review and meta‐analysisDiabetic Medicine, 2012
- Glycated haemoglobin and blood pressure‐lowering effect of cinnamon in multi‐ethnic Type 2 diabetic patients in the UK: a randomized, placebo‐controlled, double‐blind clinical trialDiabetic Medicine, 2010
- The potential of cinnamon to reduce blood glucose levels in patients with type 2 diabetes and insulin resistanceDiabetes, Obesity and Metabolism, 2009
- Antidiabetic effect ofCinnamomum cassia andCinnamomum zeylanicum In vivo andIn vitroPhytotherapy Research, 2005
- A systematic review of the content of critical appraisal toolsBMC Medical Research Methodology, 2004
- Quantifying heterogeneity in a meta‐analysisStatistics in Medicine, 2002
- Maintaining Standards: Differences between the Standard Deviation and Standard Error, and When to Use EachThe Canadian Journal of Psychiatry, 1996